SCV
Sands Capital Ventures Portfolio holdings
AUM
$508M
This Quarter Return
-14.07%
1 Year Return
+48.12%
3 Year Return
+324.3%
5 Year Return
–
10 Year Return
–
AUM
$675M
AUM Growth
+$675M
(+1.7%)
Cap. Flow
+$132M
Cap. Flow
% of AUM
19.61%
Top 10 Holdings %
Top 10 Hldgs %
95.47%
Holding
16
New
3
Increased
–
Reduced
2
Closed
–
Top Buys
| 1 |
Nu Holdings
NU
|
$85.7M |
| 2 |
Samsara
IOT
|
$9.16M |
Top Sells
| 1 |
Snowflake
SNOW
|
$34.5M |
| 2 |
DoorDash
DASH
|
$4.28M |
Sector Composition
| 1 | Technology | 36.5% |
| 2 | Healthcare | 26.22% |
| 3 | Consumer Discretionary | 13.27% |
| 4 | Financials | 12.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
UiPath
PATH
$5.83B
| $164M | 24.37% |
3,811,779
| – | – |
|
|
2
DoorDash
DASH
$104B
| $89.6M | 13.27% |
601,454
-28,763
| -5% | -$4.28M |
|
|
3
Nu Holdings
NU
$71.8B
| $85.7M | 12.7% |
+9,136,835
| New | +$85.7M |
|
|
DICE
4
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $79.7M | 11.81% |
3,148,970
| – | – |
|
|
5
Snowflake
SNOW
$77.9B
| $72.7M | 10.78% |
214,621
-101,955
| -32% | -$34.5M |
|
|
KRTX
6
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $35.1M | 5.2% |
267,895
| – | – |
|
7
Acumen Pharmaceuticals
ABOS
$82.4M
| $23.1M | 3.42% |
3,417,075
| – | – |
|
|
8
Samsara
IOT
$20.2B
| $9.16M | 1.36% |
+326,000
| New | +$9.16M |
|
9
908 Devices
MASS
$214M
| $8.45M | 1.25% |
326,427
| – | – |
|
10
Taysha Gene Therapies
TSHA
$775M
| $8.45M | 1.25% |
724,873
| – | – |
|
11
Candel Therapeutics
CADL
$322M
| $6.35M | 0.94% |
811,737
| – | – |
|
12
Repligen
RGEN
$6.79B
| $5.97M | 0.89% |
22,544
| – | – |
|
13
Tarsus Pharmaceuticals
TARS
$2.47B
| $5.85M | 0.87% |
260,000
| – | – |
|
|
SPRB
14
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
| $3.51M | 0.52% |
787,007
| – | – |
|
15
Absci
ABSI
$350M
| $474K | 0.07% |
57,804
| – | – |
|